2-(nitrooxy)ethyl apovincaminate has been researched along with vinpocetine in 5 studies
| Studies (2-(nitrooxy)ethyl apovincaminate) | Trials (2-(nitrooxy)ethyl apovincaminate) | Recent Studies (post-2010) (2-(nitrooxy)ethyl apovincaminate) | Studies (vinpocetine) | Trials (vinpocetine) | Recent Studies (post-2010) (vinpocetine) |
|---|---|---|---|---|---|
| 20 | 1 | 1 | 652 | 62 | 212 |
| Protein | Taxonomy | 2-(nitrooxy)ethyl apovincaminate (IC50) | vinpocetine (IC50) |
|---|---|---|---|
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | 7.99 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatayama, K; Hayashi, M; Horiguchi, A; Ikemoto, T; Kawarasaki, K; Kawashima, Y; Matsumoto, K; Okuyama, S; Yamazaki, R | 1 |
| Okuyama, S; Yamada, S; Yamaguchi, K | 1 |
| Araki, H; Hashimoto-Kitsukawa, S; Imagawa, Y; Kawashima, K; Kawashima, Y; Ogawa, S; Okuyama, S; Otomo, S | 1 |
| Miyata, N; Muramatsu, M; Okuyama, S; Otomo, S; Tanaka, M; Tsuchida, K; Yamaura, H | 1 |
| Gulyás, B; Vas, A | 1 |
1 review(s) available for 2-(nitrooxy)ethyl apovincaminate and vinpocetine
| Article | Year |
|---|---|
Eburnamine derivatives and the brain.
Topics: Animals; Apocynaceae; Brain; Humans; Nucleotides, Cyclic; Positron-Emission Tomography; Receptors, GABA-A; Sodium Channel Blockers; Vinca Alkaloids; Vincamine | 2005 |
4 other study(ies) available for 2-(nitrooxy)ethyl apovincaminate and vinpocetine
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates.
Topics: Animals; Cerebrovascular Circulation; Crystallography; Dogs; Female; Hemodynamics; Male; Nitro Compounds; Structure-Activity Relationship; Vasodilator Agents; Vinca Alkaloids; Vincamine | 1993 |
Effects of VA-045 on peripheral and central circulation in anesthetized dogs.
Topics: Anesthesia; Animals; Blood Circulation; Blood Pressure; Cerebrovascular Circulation; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Male; Vasodilator Agents; Vinca Alkaloids | 1995 |
Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats.
Topics: Aging; Animals; Arousal; Avoidance Learning; Behavior, Animal; Caudate Nucleus; Cerebrovascular Circulation; Corpus Striatum; Electric Stimulation; Electroencephalography; Male; Rats; Rats, Wistar; Vasodilator Agents; Vinca Alkaloids | 1994 |
Effects of VA-045, a novel apovincaminic acid derivative, on isolated blood vessels: cerebroarterial selectivity.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta; Basilar Artery; Blood Vessels; Cerebral Arteries; Coronary Vessels; Cyclic GMP; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rats; Rats, Wistar; Sensitivity and Specificity; Vasodilator Agents; Vinca Alkaloids | 1993 |